However, RNA-based NGS results, obtained via a CLIA-certified laboratory (Caris Life Sciences; Phoenix, Arizona) revealed the presence of a characteristic fusion between EWS RNA-binding protein 1 (EWSR1) and FLI1, confirming the diagnosis of ES. The gene discussed is FLI1; the disease is Ewing sarcoma.